JIP
ZBH icon

Jaffetilchin Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Jaffetilchin Investment Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-264
Closed -$28.5K – 1339
2024
Q3 		$28.5K Buy
+264
New +$28.8K ﹤0.01% 684
2021
Q4 		– Sell
-1,916
Closed -$272K – 390
2021
Q3 		$272K Sell
1,916
-2,372
-55% -$349K 0.03% 288
2021
Q2 		$658K Buy
4,288
+2,693
+169% +$436K 0.05% 225
2021
Q1 		$248K Sell
1,595
-79
-5% -$12.2K 0.03% 301
2020
Q4 		$250K Buy
+1,674
New +$236K 0.04% 242

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Jaffetilchin Investment Partners's ZBH Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 264 shares — an estimated $28.5K sold.

Jaffetilchin Investment Partners first reported a position in ZBH in Q4 2020 and held it in 5 quarters. The position peaked at $658K in Q2 2021. 1,028 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 264 Zimmer Biomet shares in Q4 2024, an estimated $28.5K.
  • Jaffetilchin Investment Partners first reported a position in Zimmer Biomet in Q4 2020 and held it in 5 quarters.
  • Jaffetilchin Investment Partners's Zimmer Biomet position peaked at $658K in Q2 2021.
  • 1,028 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.